
Gardasil HPV Vaccine Information
What is the HPV vaccine?
The vaccine, Gardasil, is the first vaccine developed to prevent
cervical cancer, precancerous genital lesions, and
genital warts due to HPV.
Who should get the HPV vaccine?
CDC recommends the HPV vaccine for all 11 and 12 year old girls. The
recommendation allows for vaccination to begin at age nine. Vaccination also is
recommended for females aged 13 through 26 years who have not been previously
vaccinated or who have not completed the full series of shots.
Are there other HPV vaccines in development?
Another HPV vaccine (being developed by GlaxoSmithKline) is in the final
stages of clinical testing, but it is not yet licensed. This vaccine would
protect against the two types of HPV that cause most cervical cancers.
How and when is the vaccine delivered?
The vaccine is given in a series of three injections over a six-month period.
The second and third doses should be given at two and six months (respectively)
after the first dose. HPV vaccine may be given at the same time as other
vaccines.
Is the HPV vaccine effective?
This vaccine is highly effective in preventing
four types of HPV in young women who have not been previously exposed to HPV.
This vaccine targets HPV types that cause up to 70% of all cervical cancers and
about 90% of genital warts. The vaccine will not treat existing HPV infections
or their complications.
Is the HPV vaccine safe?
The FDA has licensed the vaccine as safe and effective. This vaccine has been
tested in thousands of females (9 to 26 years of age) around the world. These
studies have shown no serious side effects. The most common side effect is brief
soreness at the injection site. CDC, working with the FDA, will continue to
monitor the safety of the vaccine after it is in general use.
Next: Does the vaccine contain thimerosal or mercury? »